{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:16:36Z","timestamp":1793812596013,"version":"4.6.1"},"reference-count":326,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research Trust","doi-asserted-by":"publisher","award":["525036"],"award-info":[{"award-number":["525036"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research Trust","doi-asserted-by":"publisher","award":["520488"],"award-info":[{"award-number":["520488"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022942","name":"Moondance Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U54 AG054349"],"award-info":[{"award-number":["U54 AG054349"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000898","name":"The Eli and Edythe Broad Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.imbio.2025.153089","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:08:08Z","timestamp":1750100888000},"page":"153089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Complement therapeutics in neurodegenerative diseases"],"prefix":"10.1016","volume":"230","author":[{"given":"Wioleta M.","family":"Zelek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Tenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.imbio.2025.153089_bb0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079661","article-title":"Adeno-associated virus mediated delivery of a non-membrane targeted human soluble CD59 attenuates some aspects of diabetic retinopathy in mice","volume":"8","author":"Adhi","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0025","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/alz.12833","article-title":"Therapeutic anti-amyloid \u03b2 antibodies cause neuronal disturbances","volume":"19","author":"Adhikari","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"16","key":"10.1016\/j.imbio.2025.153089_bb0030","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/1873-3468.13856","article-title":"The imitation game: a viral strategy to subvert the complement system","volume":"594","author":"Agrawal","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.imbio.2025.153089_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","article-title":"NLRP3 inflammasome in neurodegenerative disease","volume":"252","author":"Anderson","year":"2023","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0040","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211057","article-title":"Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme","volume":"219","author":"Arguello","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2025.153089_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbi.2016.11.026","article-title":"A genetic association study of CSMD1 and CSMD2 with cognitive function","volume":"61","author":"Athanasiu","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imbio.2025.153089_bb0050","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41380-018-0258-3","article-title":"Integrative approach to sporadic Alzheimer\u2019s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau","volume":"24","author":"Audrain","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.imbio.2025.153089_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113595","article-title":"Mechanisms of receptor-mediated transcytosis at the blood-brain barrier","volume":"381","author":"Baghirov","year":"2025","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.medj.2024.01.011","article-title":"Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID","volume":"5","author":"Baillie","year":"2024","journal-title":"Med"},{"issue":"22","key":"10.1016\/j.imbio.2025.153089_bb0070","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Bajic","year":"2015","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0075","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","article-title":"Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice","volume":"188","author":"Banda","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41531-019-0090-8","article-title":"Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons, neuroinflammation and widespread protein aggregation","volume":"5","author":"Bantle","year":"2019","journal-title":"NPJ Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0090","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ijms25020817","article-title":"The Importance of Complement-Mediated Immune Signaling in Alzheimer\u2019s Disease Pathogenesis","volume":"25","author":"Batista","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2025.153089_bb0095","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbi.2024.03.041","article-title":"CSMD1 regulates brain complement activity and circuit development","volume":"119","author":"Baum","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2025.153089_bb0105","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1523\/JNEUROSCI.3932-10.2011","article-title":"Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression","volume":"31","author":"Benoit","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb0110","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.4049\/jimmunol.1103760","article-title":"Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells","volume":"188","author":"Benoit","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1074\/jbc.M112.400168","article-title":"C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-beta Neurotoxicity","volume":"288","author":"Benoit","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2025.153089_bb0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/bj2160385","article-title":"Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes","volume":"216","author":"Bensa","year":"1983","journal-title":"Biochem.J"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144348","article-title":"Complement C3a receptor-mediated vascular dysfunction: a complex interplay between aging and neurodegeneration","volume":"131","author":"Bhatia","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0130","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1073\/pnas.1218497110","article-title":"Reactive astrocytes secrete lcn2 to promote neuron death","volume":"110","author":"Bi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb0135","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1089\/neu.2016.4701","article-title":"The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury","volume":"34","author":"Biggins","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.imbio.2025.153089_bb0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-immunol-101921-035639","article-title":"Complement in the Brain: Contributions to Neuroprotection, Neuronal Plasticity, and Neuroinflammation","volume":"41","author":"Bohlson","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/scipharm87010006","article-title":"Overcoming the Blood\u2013Brain Barrier. Challenges and Tricks for CNS Drug Delivery","volume":"87","author":"Bors","year":"2019","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.imbio.2025.153089_bb0150","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1038\/s41467-023-37437-5","article-title":"Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers","volume":"14","author":"Brase","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2025.153089_bb0155","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury","volume":"35","author":"Brennan","year":"2015","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.imbio.2025.153089_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98254","article-title":"Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2","volume":"4","author":"Brennan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.imbio.2025.153089_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1742-2094-9-220","article-title":"Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice","volume":"9","author":"Britschgi","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0170","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/dneu.22024","article-title":"Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism","volume":"72","author":"Brown","year":"2012","journal-title":"Dev Neurobiol."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0175","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jnc.15327","article-title":"Microglial phagocytosis of neurons in neurodegeneration, and its regulation","volume":"158","author":"Butler","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.imbio.2025.153089_bb0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbi.2025.03.026","article-title":"The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans","volume":"127","author":"Byrne","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb0185","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s12264-023-01055-4","article-title":"A Systematic Investigation of Complement and Coagulation-Related Protein in Autism Spectrum Disorder Using Multiple Reaction Monitoring Technology","volume":"39","author":"Cao","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-022-01404-w","article-title":"Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models","volume":"10","author":"Carpanini","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","article-title":"Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression","volume":"19","author":"Carvalho","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11481-024-10107-z","article-title":"Complement C3 From Astrocytes Plays Significant Roles in Sustained Activation of Microglia and Cognitive Dysfunctions Triggered by Systemic Inflammation After Laparotomy in Adult Male Mice","volume":"19","author":"Chen","year":"2024","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0205","article-title":"Complement C5a Receptor Signaling Alters Stress Responsiveness and Modulates Microglia Following Chronic Stress Exposure","volume":"4","author":"Chen","year":"2024","journal-title":"Biol. Psychiatry Glob Open Sci."},{"key":"10.1016\/j.imbio.2025.153089_bb0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbi.2024.09.022","article-title":"Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson\u2019s disease","volume":"123","author":"Chi","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1472-8206.2010.00811.x","article-title":"Complement receptor 3 (CD11b\/CD18) is implicated in the elimination of \u03b2-amyloid peptides","volume":"25","author":"Choucair-Jaafar","year":"2011","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"17","key":"10.1016\/j.imbio.2025.153089_bb0220","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1073\/pnas.0913449107","article-title":"Enhanced synaptic connectivity and epilepsy in C1q knockout mice","volume":"107","author":"Chu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7480","key":"10.1016\/j.imbio.2025.153089_bb0225","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature12776","article-title":"Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways","volume":"504","author":"Chung","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2025.153089_bb0230","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1073\/pnas.1609896113","article-title":"Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes","volume":"113","author":"Chung","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2025.153089_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1189\/jlb.3A0614-278R","article-title":"Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation","volume":"97","author":"Clarke","year":"2015","journal-title":"J.Leukoc.Biol."},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb0240","doi-asserted-by":"crossref","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","article-title":"Aaging induces A1-like astrocyte reactivity","volume":"115","author":"Clarke","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2025.153089_bb0245","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.molimm.2005.11.015","article-title":"Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis","volume":"43","author":"Cole","year":"2006","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2025.153089_bb0250","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41593-020-0672-0","article-title":"The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development","volume":"23","author":"Cong","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb0255","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.1403068","article-title":"Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth","volume":"194","author":"Coulthard","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","article-title":"Complement: The Emerging Architect of the Developing Brain","volume":"41","author":"Coulthard","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12974-024-03052-4","article-title":"TYROBP\/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration","volume":"21","author":"Creus-Muncunill","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0270","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.20162011","article-title":"Microglial complement receptor 3 regulates brain A\u03b2 levels through secreted proteolytic activity","volume":"214","author":"Czirr","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2025.153089_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152388","article-title":"Peripheral control of psychiatric disorders: Focus on OCD. Are we there yet?","volume":"123","author":"D'Acquisto","year":"2023","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0280","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/glia.24355","article-title":"Complement receptor 1 is expressed on brain cells and in the human brain","volume":"71","author":"Daskoulidou","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.imbio.2025.153089_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/7854_2024_524","article-title":"Involvement of Complement in Alzheimer\u2019s Disease: From Genetics Through Pathology to Therapeutic Strategies","volume":"69","author":"Daskoulidou","year":"2025","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bib1601","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J Proteome Res."},{"key":"10.1016\/j.imbio.2025.153089_bb0290","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12974-019-1683-1","article-title":"Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex","volume":"17","author":"Datta","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0295","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.imbio.2025.153089_bb0305","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4103\/1673-5374.306064","article-title":"Astrocytes: a double-edged sword in neurodegenerative diseases","volume":"16","author":"Ding","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0310","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/gbb.12016","article-title":"Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253","volume":"12","author":"Donohoe","year":"2013","journal-title":"Genes Brain Behav."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0315","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1038\/s41380-021-01081-6","article-title":"Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes","volume":"26","author":"Druart","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0320","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/alz.13678","article-title":"Astroglial activation: Current concepts and future directions","volume":"20","author":"Edison","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"2\u20133","key":"10.1016\/j.imbio.2025.153089_bb0325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","article-title":"Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study","volume":"57","author":"Eikelenboom","year":"1982","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.imbio.2025.153089_bb0330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12474","article-title":"Evolution of the complement system: from defense of the single cell to guardian of the intravascular space","volume":"274","author":"Elvington","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2025.153089_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1474012","article-title":"Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron-glia crosstalk in Alzheimer\u2019s disease","volume":"16","author":"\u00c9vora","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0340","first-page":"19","article-title":"Complement C3 Expression Is Decreased in Autism Spectrum Disorder Subjects and Contributes to Behavioral Deficits in Rodents","volume":"3","author":"Fagan","year":"2017","journal-title":"Mol Neuropsychiatry."},{"issue":"24","key":"10.1016\/j.imbio.2025.153089_bb0345","doi-asserted-by":"crossref","first-page":"17297","DOI":"10.3390\/ijms242417297","article-title":"Microglia Modulate Neurodevelopment in Autism Spectrum Disorder and Schizophrenia","volume":"24","author":"Fan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb0350","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/pathogens13110974","article-title":"Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review","volume":"13","author":"Farrer","year":"2024","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb0355","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/febs.15772","article-title":"Complement cascade functions during brain development and neurodegeneration","volume":"289","author":"Fatoba","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.imbio.2025.153089_bb0360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2018.00247","article-title":"Microglia Response During Parkinson\u2019s Disease: Alpha-Synuclein Intervention","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bib1609","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70104","article-title":"Biomarkers of blood-brain barrier and neurovascular unit integrity in human cognitive impairment and dementia","volume":"21","author":"French","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"29","key":"10.1016\/j.imbio.2025.153089_bb0365","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","article-title":"Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer\u2019s disease","volume":"24","author":"Fonseca","year":"2004","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bib1607","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer\u2019s disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0370","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-8-4","article-title":"Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease","volume":"8","author":"Fonseca","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2025.153089_bb0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-017-0814-9","article-title":"Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain","volume":"14","author":"Fonseca","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2025.153089_bb0380","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnins.2019.00164","article-title":"Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies","volume":"13","author":"Foster","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb0385","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.4049\/jimmunol.0902232","article-title":"C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells","volume":"183","author":"Fraser","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0390","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.2009.06494.x","article-title":"C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production","volume":"112","author":"Fraser","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.imbio.2025.153089_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697313","article-title":"Expanding Horizons in Complement Analysis and Quality Control","volume":"12","author":"Frazer-Abel","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0400","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/glia.22331","article-title":"Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar A\u03b2 by microglia","volume":"60","author":"Fu","year":"2012","journal-title":"Glia"},{"issue":"13","key":"10.1016\/j.imbio.2025.153089_bb0405","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.3390\/molecules28135206","article-title":"Evaluation of Novel B1R\/B2R Agonists Containing TRIOZAN\u2122 Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease","volume":"28","author":"Gagnon","year":"2023","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb0410","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood-brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0415","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41380-024-02750-y","article-title":"Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment","volume":"30","author":"Gallwitz","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0420","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther."},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb0425","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167501","article-title":"Complement C3aR depletion reverses HIF-1\u03b1-induced metabolic impairment and enhances microglial response to A\u03b2 pathology","volume":"133","author":"Gedam","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bib1603","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-021-02042-1","article-title":"Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy","volume":"40","author":"Gialeli","year":"2021","journal-title":"J Exp Clin Cancer Res."},{"key":"10.1016\/j.imbio.2025.153089_bb0430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2018.05.023","article-title":"Novel potential inhibitors of complement system and their roles in complement regulation and beyond","volume":"102","author":"Gialeli","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0435","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/ITT.S305420","article-title":"The Role of Complement in Synaptic Pruning and Neurodegeneration","volume":"10","author":"Gomez-Arboledas","year":"2021","journal-title":"Immunotargets Ther."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0440","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-022-01416-6","article-title":"C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease","volume":"10","author":"Gomez-Arboledas","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0445","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/alz.13682","article-title":"C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease","volume":"20","author":"Gomez-Arboledas","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.imbio.2025.153089_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.866444","article-title":"Synapse Formation and Function Across Species: Ancient Roles for CCP, CUB, and TSP-1 Structural Domains","volume":"16","author":"Gonz\u00e1lez-Calvo","year":"2022","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0455","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.imbio.2016.06.146","article-title":"Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1","volume":"221","author":"Gordon","year":"2016","journal-title":"Immunobiol"},{"key":"10.1016\/j.imbio.2025.153089_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15096","article-title":"Developmental activities of the complement pathway in migrating neurons","volume":"8","author":"Gorelik","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0465","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1038\/s41467-022-33797-6","article-title":"Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia","volume":"13","author":"Gracias","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0470","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-021-02225-9","article-title":"Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity","volume":"18","author":"Gregersen","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2025.153089_bb0475","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/nan.12575","article-title":"Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis","volume":"46","author":"Gregory","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"13","key":"10.1016\/j.imbio.2025.153089_bb0480","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0485","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41593-020-00796-z","article-title":"Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease","volume":"24","author":"Guttikonda","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0490","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000524587","article-title":"Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex","volume":"15","author":"Gytz Olesen","year":"2023","journal-title":"J. Innate Immun."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0495","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0500","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3233\/JAD-160420","article-title":"Complement Biomarkers as Predictors of Disease Progression in Alzheimer\u2019s Disease","volume":"54","author":"Hakobyan","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb0505","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.imbio.2025.153089_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Front. Drug Deliv."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0515","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00406-022-01409-5","article-title":"Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability","volume":"272","author":"Hatzimanolis","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0520","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/nbdi.2000.0380","article-title":"Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome","volume":"8","author":"Head","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"5-6","key":"10.1016\/j.imbio.2025.153089_bb0525","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000491439","article-title":"Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications","volume":"10","author":"Heesterbeek","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.imbio.2025.153089_bb0530","article-title":"Neuroinflammation in Alzheimer disease","author":"Heneka","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0535","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","article-title":"Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss","volume":"12","author":"Hernandez","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0540","doi-asserted-by":"crossref","DOI":"10.1177\/1759091416687871","article-title":"C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta","volume":"9","author":"Hernandez","year":"2017","journal-title":"ASN Neuro."},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb0545","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.imbio.2025.153089_bb0550","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.3390\/ijms25179477","article-title":"Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors","volume":"25","author":"Hillmen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb0555","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ijrobp.2023.12.017","article-title":"Pharmacologic Manipulation of Complement Receptor 3 Prevents Dendritic Spine Loss and Cognitive Impairment After Acute Cranial Radiation","volume":"119","author":"Hinkle","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.imbio.2025.153089_bb0560","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2016.08.019","article-title":"Macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins are modulated by complement protein C1q","volume":"253","author":"Ho","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imbio.2025.153089_bb0565","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj2685","article-title":"Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury","volume":"373","author":"Holden","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.imbio.2025.153089_bb0570","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00521","article-title":"Plasma brain-related biomarkers and potential therapeutic targets in pediatric ECMO","volume":"22","author":"Hong","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1710-1492-6-3","article-title":"Alterations in the complement cascade in post-traumatic stress disorder","volume":"6","author":"Hovhannisyan","year":"2010","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0585","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41590-018-0064-8","article-title":"Innate immune responses to trauma","volume":"19","author":"Huber-Lang","year":"2018","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0590","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/1352458512438238","article-title":"Systemic complement profiling in multiple sclerosis as a biomarker of disease state","volume":"18","author":"Ingram","year":"2012","journal-title":"Mult. Scler."},{"issue":"2-3","key":"10.1016\/j.imbio.2025.153089_bb0595","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imbio.2025.153089_bb0600","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1523\/JNEUROSCI.3850-15.2016","article-title":"Megf10 Is a Receptor for C1Q That Mediates Clearance of Apoptotic Cells by Astrocytes","volume":"36","author":"Iram","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb0605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molimm.2014.06.039","article-title":"Complement and blood-brain barrier integrity","volume":"61","author":"Jacob","year":"2014","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0610","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Smeyne RJ. Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imbio.2025.153089_bb0615","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.molimm.2015.09.004","article-title":"Co-ordinated expression of innate immune molecules during mouse neurulation","volume":"68","author":"Jeanes","year":"2015","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb0620","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70039","article-title":"Torque Teno Virus Control by the Classical Pathway of Complement Activation-A Retrospective Analysis From a First-in-Human Trial Utilizing Sutimlimab","volume":"96","author":"Kapps","year":"2024","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0625","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer's disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"545","key":"10.1016\/j.imbio.2025.153089_bb0630","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0635","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41467-025-57108-x","article-title":"Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution","volume":"16","author":"Khoury","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb0640","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350813","article-title":"Intracellular complement and immunometabolism: The advantages of compartmentalization","volume":"54","author":"King","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1368399","article-title":"External quality assurance program for diagnostic complement laboratories: evaluation of the results of the past seven years","volume":"15","author":"Kirschfink","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.782082","article-title":"The Gut-Brain Axis and Its Relation to Parkinson's Disease: A Review","volume":"13","author":"Klann","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bib1605","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbrc.2007.04.055","article-title":"Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112","volume":"357","author":"Klegeris","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"issue":"14","key":"10.1016\/j.imbio.2025.153089_bb0655","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0660","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12974-024-03036-4","article-title":"Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes","volume":"21","author":"Kodosaki","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2025.153089_bb0665","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2017.12.012","article-title":"Complement system biomarkers in first episode psychosis","volume":"204","author":"Kopczynska","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.imbio.2025.153089_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.599771","article-title":"Identification of Neuronal Pentraxins as Synaptic Binding Partners of C1q and the Involvement of NP1 in Synaptic Pruning in Adult Mice","volume":"11","author":"Kov\u00e1cs","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0675","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","article-title":"The complement cascade in Alzheimer's disease: a systematic review and meta-analysis","volume":"26","author":"Krance","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.imbio.2025.153089_bb0680","article-title":"C5aR1 inhibition alleviates cranial radiation-induced cognitive decline","author":"Krattli","year":"2024","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb0685","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsomega.9b03735","article-title":"Noakes PG, Taylor SM, Woodruff TM. Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice","volume":"5","author":"Kumar","year":"2020","journal-title":"ACS Omega"},{"issue":"17","key":"10.1016\/j.imbio.2025.153089_bb0690","first-page":"2","article-title":"A Phase 2 Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous ANX005 in Patients with, or at Risk of, Manifest Huntington\u2019s Disease (HD) (S32.009)","volume":"100","author":"Kumar","year":"2023","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.imbio.2025.153089_bb0695","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.3390\/ijms252212164","article-title":"Gut Microbiota and Immune System Dynamics in Parkinson's and Alzheimer's Diseases","volume":"25","author":"Kustrimovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0700","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.imbio.2025.153089_bb0705","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-015-0369-6","article-title":"Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease","volume":"12","author":"Landlinger","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb0710","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imbio.2025.153089_bb0715","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","article-title":"Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis","volume":"15","author":"Lee","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0720","doi-asserted-by":"crossref","first-page":"24482","DOI":"10.1038\/s41598-024-75983-0","article-title":"Serum proteomic changes related to residual impairment in remittent depression are associated with immune and inflammatory processes","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb0725","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.1900371","article-title":"The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity","volume":"202","author":"Li","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108074","article-title":"Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists","volume":"100","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imbio.2025.153089_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.591398","article-title":"The \"C3aR Antagonist\" SB290157 is a Partial C5aR2 Agonist","volume":"11","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0740","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer\u2019s Disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"issue":"7638","key":"10.1016\/j.imbio.2025.153089_bb0745","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2025.153089_bb0750","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12864-016-2746-7","article-title":"Transcriptome analysis of human brain tissue identifies reduced expression of complement complex C1Q Genes in Rett syndrome","volume":"17","author":"Lin","year":"2016","journal-title":"BMC Genomics"},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb0755","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/neu.2019.6741","article-title":"Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study","volume":"37","author":"Lindblad","year":"2020","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0760","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0765","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer\u2019s Disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.imbio.2025.153089_bb0770","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0775","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/JLB.3MIR0220-270R","article-title":"Complement: Bridging the innate and adaptive immune systems in sterile inflammation","volume":"108","author":"Lo","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imbio.2025.153089_bb0780","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0785","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imbio.2025.153089_bb0790","article-title":"SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?","volume":"42","author":"Luo","year":"2024","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.imbio.2025.153089_bb0795","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front. Immunol."},{"issue":"25","key":"10.1016\/j.imbio.2025.153089_bb0800","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0805","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40478-021-01179-6","article-title":"Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury","volume":"9","author":"Mallah","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0810","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1158\/0008-5472.CAN-20-2565","article-title":"Glia-Selective Deletion of Complement C1q Prevents Radiation-Induced Cognitive Deficits and Neuroinflammation","volume":"81","author":"Markarian","year":"2021","journal-title":"Cancer Res."},{"issue":"40","key":"10.1016\/j.imbio.2025.153089_bb0815","doi-asserted-by":"crossref","first-page":"33733","DOI":"10.1074\/jbc.M112.341339","article-title":"Annexin A2 and A5 serve as new ligands for C1Q on apoptotic cells","volume":"287","author":"Martin","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0820","first-page":"456","article-title":"Complement therapeutics in inflammatory diseases: Promoting immune balance while minimizing adverse effects","volume":"218","author":"Mastellos","year":"2013","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0825","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0830","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/7651_2021_429","article-title":"Human Induced Pluripotent Stem Cell-Derived Microglia (hiPSC-Microglia)","volume":"2454","author":"McQuade","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.imbio.2025.153089_bb0835","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2000.tb05615.x","article-title":"Opsonization of apoptotic cells. Implications for uptake and autoimmunity","volume":"926","author":"Mevorach","year":"2000","journal-title":"Ann.N.Y.Acad.Sci."},{"key":"10.1016\/j.imbio.2025.153089_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1167886","article-title":"Clusterin\/apolipoprotein J, its isoforms and Alzheimer's disease","volume":"15","author":"Milinkeviciute","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb0845","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm6131","article-title":"Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies","volume":"385","author":"Minhas","year":"2024","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0850","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaj2195","article-title":"Complement C5a Receptor is the Key Initiator of Neutrophil Adhesion Igniting Immune Complex-induced Arthritis","volume":"2","author":"Miyabe","year":"2017","journal-title":"Sci. Immunol."},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb0855","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cells9122623","article-title":"Neuron-Astrocyte Interactions in Parkinson's Disease","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.imbio.2025.153089_bb0860","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nantod.2017.03.001","article-title":"Complement activation turnover on surfaces of nanoparticles","volume":"15","author":"Moghimi","year":"2017","journal-title":"Nano Today"},{"key":"10.1016\/j.imbio.2025.153089_bb0865","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2020.05.036","article-title":"Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies","volume":"222","author":"Mongan","year":"2020","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0870","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.imbio.2015.04.006","article-title":"The membrane attack complex as an inflammatory trigger","volume":"221","author":"Morgan","year":"2015","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb0875","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb0880","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-3089.2005.00237.x","article-title":"\u201cHomologous restriction\u201d in complement lysis: roles of membrane complement regulators","volume":"12","author":"Morgan","year":"2006","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.imbio.2025.153089_bb0885","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.semcdb.2017.06.009","article-title":"Molecular cell biology of complement membrane attack","volume":"72","author":"Morgan","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb0890","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","article-title":"Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma","volume":"24","author":"Narsinh","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0895","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschemneuro.2c00019","article-title":"Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson's Disease with Cognitive ImpairmentA Proteomics-ELISA-Based Study","volume":"13","author":"Naskar","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb0900","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1396520","article-title":"The complement system in neurodegenerative and inflammatory diseases of the central nervous system","volume":"15","author":"Negro-Demontel","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.imbio.2025.153089_bib1610","article-title":"Complement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampus","author":"Nguyen","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0905","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2013","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0910","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JPD-202310","article-title":"Cerebrospinal Fluid Profiles in Parkinson's Disease: No Accumulation of Glucosylceramide, but Significant Downregulation of Active Complement C5 Fragment","volume":"11","author":"Niimi","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0915","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.imbio.2025.153089_bb0920","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-017-0794-9","article-title":"HIV induces expression of complement component C3 in astrocytes by NF-kappaB-dependent activation of interleukin-6 synthesis","volume":"14","author":"Nitkiewicz","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"80","key":"10.1016\/j.imbio.2025.153089_bb0925","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-94-017-8881-6_3","article-title":"Evolution of the complement system","volume":"2014","author":"Nonaka","year":"2014","journal-title":"Subcell. Biochem."},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb0930","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.imbio.2025.153089_bb0935","article-title":"Model organism development and evaluation for late-onset Alzheimer's disease: MODEL-AD","volume":"6","author":"Oblak","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0940","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41416-022-02116-7","article-title":"Thinking inside the box: intracellular roles for complement system proteins come into focus","volume":"128","author":"O'Brien","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.imbio.2025.153089_bb0945","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fncel.2014.00380","article-title":"Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis","volume":"8","author":"Orsini","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb0950","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.59058","article-title":"Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial","volume":"8","author":"Paganoni","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.imbio.2025.153089_bb0955","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.4049\/jimmunol.180.4.2329","article-title":"C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition","volume":"180","author":"Paidassi","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb0960","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1038\/s41380-021-01266-z","article-title":"Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE epsilon2 protective effect in Alzheimer disease","volume":"26","author":"Panitch","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb0965","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40035-021-00269-8","article-title":"Extensive frontal focused ultrasound mediated blood-brain barrier opening for the treatment of Alzheimer's disease: a proof-of-concept study","volume":"10","author":"Park","year":"2021","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.imbio.2025.153089_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102282","article-title":"Complement drives circuit modulation in the adult brain","volume":"214","author":"Parker","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.imbio.2025.153089_bb0975","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1096\/fj.11-202382","article-title":"Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis","volume":"26","author":"Pavlovski","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.imbio.2025.153089_bb0980","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1046\/j.1523-1755.1999.00722.x","article-title":"C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor","volume":"56","author":"Peake","year":"1999","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb0985","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/cells10071812","article-title":"The Complement System: A Powerful Modulator and Effector of Astrocyte Function in the Healthy and Diseased Central Nervous System","volume":"10","author":"Pekna","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb0990","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1007\/s11064-021-03419-6","article-title":"Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury","volume":"46","author":"Pekna","year":"2021","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb0995","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imbio.2025.153089_bb1000","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1523\/JNEUROSCI.4473-12.2015","article-title":"Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo","volume":"35","author":"Peterson","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb1005","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163359","article-title":"Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease","volume":"9","author":"Pons-Espinal","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.imbio.2025.153089_bb1010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768198","article-title":"C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury","volume":"12","author":"Pozo-Rodrig\u00e1lvarez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.604812","article-title":"Hyperactive Behavior and Altered Brain Morphology in Adult Complement C3a Receptor Deficient Mice","volume":"12","author":"Pozo-Rodrig\u00e1lvarez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molimm.2021.10.006","article-title":"Complement multiplex testing: Concept, promises and pitfalls","volume":"140","author":"Proh\u00e1szka","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140966","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.1700318","article-title":"Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse","volume":"199","author":"Quell","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1040","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","article-title":"Complement: a novel factor in basal and ischemia-induced neurogenesis","volume":"25","author":"Rahpeymai","year":"2006","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.imbio.2025.153089_bb1050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nri.2017.97","article-title":"Complement in cancer: untangling an intricate relationship","volume":"18","author":"Reis","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3171\/2022.9.JNS221565","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes","volume":"139","author":"Rezai","year":"2022","journal-title":"J. Neurosurg."},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb1065","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","article-title":"Complement in immune and inflammatory disorders: therapeutic interventions","volume":"190","author":"Ricklin","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1075","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-019-0055-y","article-title":"Therapeutic targeting of the complement system","author":"Ricklin","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.imbio.2025.153089_bb1080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/hmg\/ddl035","article-title":"SRPX2 mutations in disorders of language cortex and cognition","volume":"15","author":"Roll","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb1085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng.757","article-title":"Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome","volume":"43","author":"Rooryck","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imbio.2025.153089_bb1090","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022113246","article-title":"Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models","volume":"42","author":"Rueda-Carrasco","year":"2023","journal-title":"EMBO J."},{"key":"10.1016\/j.imbio.2025.153089_bb1095","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000177","article-title":"Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease","volume":"3","author":"Ruiz-Martinez","year":"2017","journal-title":"Neurol. Genet"},{"key":"10.1016\/j.imbio.2025.153089_bb1105","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer\u2019s disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb1110","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1115","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1038\/s41467-024-51163-6","article-title":"C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model","volume":"15","author":"Schartz","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bib1604","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12974-020-02024-8","article-title":"The good, the bad, and the opportunities of the complement system in neurodegenerative disease","volume":"17","author":"Schartz","year":"2020","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.imbio.2025.153089_bb1120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958273","article-title":"C1q as a target molecule to treat human disease: What do mouse studies teach us?","volume":"13","author":"Schulz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1125","doi-asserted-by":"crossref","unstructured":"Scott-Hewitt, N., Mahoney, M., Huang, Y., et al., 2024. Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain. Cell 187: 4193-212 e24.","DOI":"10.1016\/j.cell.2024.05.058"},{"issue":"7589","key":"10.1016\/j.imbio.2025.153089_bb1130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"issue":"7589","key":"10.1016\/j.imbio.2025.153089_bib1602","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.imbio.2025.153089_bb1135","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/cells13171426","article-title":"Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease","volume":"13","author":"Serradas","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.imbio.2025.153089_bb1140","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","article-title":"Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline","volume":"35","author":"Shi","year":"2015","journal-title":"J. Neurosci."},{"issue":"392","key":"10.1016\/j.imbio.2025.153089_bb1145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","volume":"9","author":"Shi","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imbio.2025.153089_bb1150","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/stem.225","article-title":"Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells","volume":"27","author":"Shinjyo","year":"2009","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.imbio.2025.153089_bb1160","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1182\/blood-2016-05-719757","article-title":"C1q and HMGB1 reciprocally regulate human macrophage polarization","volume":"128","author":"Son","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2025.153089_bb1165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000044876","article-title":"Compartmental localization of complement component transcripts in the normal human kidney","volume":"78","author":"Song","year":"1998","journal-title":"Nephron"},{"issue":"18","key":"10.1016\/j.imbio.2025.153089_bb1170","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.3390\/ijms221810118","article-title":"Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms","volume":"22","author":"Song","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2025.153089_bb1175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00011-014-0762-0","article-title":"Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins","volume":"63","author":"Spivia","year":"2014","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.imbio.2025.153089_bb1180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/89923","article-title":"Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli","volume":"7","author":"Springall","year":"2001","journal-title":"Nat.Med."},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb1185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079501","article-title":"Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1","volume":"8","author":"Steen","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb1190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0271678X231153281","article-title":"Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications","volume":"43","author":"Steinruecke","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14728222.2023.2177532","article-title":"The case for complement component 5 as a target in neurodegenerative disease","volume":"27","author":"Stennett","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.imbio.2025.153089_bb1200","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","article-title":"A dramatic increase of C1q protein in the CNS during normal aging","volume":"33","author":"Stephan","year":"2013","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb1205","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2025.153089_bb1210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/brain\/aww314","article-title":"Complement peptide C3a stimulates neural plasticity after experimental brain ischaemia","volume":"140","author":"Stokowska","year":"2017","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb1215","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162253","article-title":"Complement C3a treatment accelerates recovery after stroke via modulation of astrocyte reactivity and cortical connectivity","volume":"133","author":"Stokowska","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0002-9440(10)64753-0","article-title":"Temporal accrual of complement proteins in amyloid plaques in Down\u2019s syndrome with Alzheimer\u2019s disease","volume":"156","author":"Stoltzner","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imbio.2025.153089_bb1225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","article-title":"Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease","volume":"9","author":"Subramaniam","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb1230","article-title":"Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease","volume":"9","author":"Sukoff-Rizzo","year":"2023","journal-title":"Alzheimers Dement (N Y)"},{"issue":"20","key":"10.1016\/j.imbio.2025.153089_bb1235","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","article-title":"Human microglial state dynamics in Alzheimer's disease progression","volume":"186","author":"Sun","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2025.153089_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2024.102614","article-title":"C3aR in the medial prefrontal cortex modulates the susceptibility to LPS-induced depressive-like behaviors through glutamatergic neuronal excitability","volume":"236","author":"Sun","year":"2024","journal-title":"Prog. Neurobiol."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb1245","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.imbio.2025.153089_bb1250","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018101064","article-title":"Systemic inflammation impairs microglial clearance through NLRP3 inflammasome","volume":"38","author":"Tejera","year":"2019","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1255","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1260","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-025-01073-y","article-title":"Knowing the enemy: strategic targeting of complement to treat Alzheimer disease","author":"Tenner","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.imbio.2025.153089_bb1265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","article-title":"New tricks for an ancient system: Physiological and pathological roles of complement in the CNS","volume":"102","author":"Tenner","year":"2018","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb1270","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.imbio.2025.153089_bb1275","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3390\/genes12121990","article-title":"Genetic Insights into the Impact of Complement in Alzheimer's Disease","volume":"12","author":"Torvell","year":"2021","journal-title":"Genes (Basel)"},{"issue":"29","key":"10.1016\/j.imbio.2025.153089_bb1280","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1074\/jbc.M115.708446","article-title":"Complement Membrane Attack and Tumorigenesis: A SYSTEMS BIOLOGY APPROACH","volume":"291","author":"Towner","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2025.153089_bb1285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907804","article-title":"Neuroinflammation in neurodegeneration via microbial infections","volume":"13","author":"Tran","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","article-title":"Glial phagocytic clearance in Parkinson's disease","volume":"14","author":"Tremblay","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.imbio.2025.153089_bb1295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-024-01788-5","article-title":"Hereditary C1q Deficiency is Associated with Type 1 Interferon-Pathway Activation and a High Risk of Central Nervous System Inflammation","volume":"44","author":"Triaille","year":"2024","journal-title":"J. Clin. Immunol."},{"issue":"Pt 13","key":"10.1016\/j.imbio.2025.153089_bb1300","first-page":"2903","article-title":"The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation","volume":"126","author":"Triantafilou","year":"2013","journal-title":"J. Cell Sci."},{"issue":"7906","key":"10.1016\/j.imbio.2025.153089_bb1305","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia","volume":"604","author":"Trubetskoy","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12974-022-02573-0","article-title":"Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study","volume":"19","author":"van der Ende","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2025.153089_bb1315","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.174.4.2353","article-title":"Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation","volume":"174","author":"Van","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nm0197-77","article-title":"Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer\u2019s disease pathogenesis","volume":"3","author":"Velazquez","year":"1997","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb1325","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/alz.12799","article-title":"Complement dysregulation and Alzheimer's disease in Down syndrome","volume":"19","author":"Veteleanu","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1330","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12974-023-02850-6","article-title":"Alzheimer's disease-associated complement gene variants influence plasma complement protein levels","volume":"20","author":"Veteleanu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.imbio.2025.153089_bb1335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1216457","article-title":"COVID, complement, and the brain","volume":"14","author":"Vlaicu","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb1340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1208\/s12248-021-00630-9","article-title":"The Nano-War Against Complement Proteins","volume":"23","author":"Wang","year":"2021","journal-title":"AAPS J."},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb1345","article-title":"The role of C5a in acute lung injury induced by highly pathogenic viral infections","volume":"4","author":"Wang","year":"2015","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.imbio.2025.153089_bb1350","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.aaz2288","article-title":"Microglia mediate forgetting via complement-dependent synaptic elimination","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb1355","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.apsb.2021.03.007","article-title":"Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","article-title":"Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation","volume":"10","author":"Wang","year":"2021","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.imbio.2025.153089_bb1365","article-title":"Therapeutically targeting the classical complement pathway with antisense oligonucleotides in Alzheimer\u2019s disease","author":"Wang","year":"2024","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","article-title":"Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease","volume":"52","author":"Werneburg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2025.153089_bb1375","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome - the intracellular complement system","volume":"19","author":"West","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.imbio.2025.153089_bb1380","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12852","article-title":"Complement and human T cell metabolism: Location, location, location","volume":"295","author":"West","year":"2020","journal-title":"Immunol. Rev."},{"issue":"10424","key":"10.1016\/j.imbio.2025.153089_bb1385","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2025.153089_bb1390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2021.09.005","article-title":"Complement C3 and C3aR mediate different aspects of emotional behaviours; relevance to risk for psychiatric disorder","volume":"99","author":"Westacott","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imbio.2025.153089_bb1395","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.imbio.2025.153089_bb1400","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","article-title":"Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington's disease","volume":"29","author":"Wilton","year":"2023","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb1405","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141694","article-title":"Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration","volume":"131","author":"Winkler","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.imbio.2025.153089_bb1410","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.cmi.2018.02.002","volume":"24","author":"Winthrop","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.imbio.2025.153089_bb1415","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2015.00220","article-title":"A Commentary On: \"NF\u03baB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer's Disease\". A cautionary note regarding C3aR","volume":"6","author":"Woodruff","year":"2015","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2025.153089_bb1420","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.imbio.2025.153089_bb1425","first-page":"143","article-title":"Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors","volume":"632","author":"Woodruff","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1430","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"NeuroMolecular Med."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12987-022-00374-4","article-title":"VHHs as tools for therapeutic protein delivery to the central nervous system","volume":"19","author":"Wouters","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.imbio.2025.153089_bb1440","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-016-0485-y","article-title":"Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain","volume":"13","author":"Wu","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb1445","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","article-title":"Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy","volume":"28","author":"Wu","year":"2019","journal-title":"Cell Rep."},{"issue":"2111-23","key":"10.1016\/j.imbio.2025.153089_bb1450","article-title":"Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy","volume":"28","author":"Wu","year":"2019","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.imbio.2025.153089_bb1455","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer\u2019s mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2025.153089_bb1460","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-022-00547-7","article-title":"Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia","volume":"17","author":"Xia","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1465","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12306","article-title":"Helicobacter pylori-derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3-C3aR signalling","volume":"12","author":"Xie","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.imbio.2025.153089_bb1470","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41593-019-0491-3","article-title":"Single-cell transcriptomic profiling of the aging mouse brain","volume":"22","author":"Ximerakis","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.imbio.2025.153089_bb1475","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fnagi.2019.00279","article-title":"The immune system drives synapse loss during lipopolysaccharide-induced learning and memory impairment in mice","volume":"11","author":"Xin","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb1480","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.2300630","article-title":"Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical Analogs","volume":"212","author":"Xu","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1485","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnmol.2018.00063","article-title":"Enteroviral infection: the forgotten link to amyotrophic lateral sclerosis?","volume":"11","author":"Xue","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1490","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12974-024-03234-0","article-title":"Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease","volume":"21","author":"Yao","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.imbio.2025.153089_bb1495","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","article-title":"Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice","volume":"24","author":"Yilmaz","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1500","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41537-023-00409-1","article-title":"Association of elevated levels of peripheral complement components with cortical thinning and impaired logical memory in drug-na\u00efve patients with first-episode schizophrenia","volume":"9","author":"Yu","year":"2023","journal-title":"Schizophrenia (Heidelb)."},{"key":"10.1016\/j.imbio.2025.153089_bb1505","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108518","article-title":"C1q is essential for myelination in the central nervous system (CNS)","volume":"26","author":"Yu","year":"2023","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.imbio.2025.153089_bb1510","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/molecules23061289","article-title":"Strategies for enhancing the permeation of CNS-active drugs through the blood-brain barrier: A review","volume":"23","author":"Zeiadeh","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.imbio.2025.153089_bb1515","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","article-title":"Targeting complement in neurodegeneration: challenges, risks, and strategies","volume":"43","author":"Zelek","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.imbio.2025.153089_bb1520","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molimm.2019.07.030","article-title":"Compendium of current complement therapeutics","volume":"114","author":"Zelek","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1525","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molimm.2019.07.030","article-title":"Compendium of current complement therapeutics","volume":"114","author":"Zelek","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2025.153089_bb1530","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbi.2024.03.017","article-title":"Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia","volume":"118","author":"Zelek","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb1535","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/awae278","article-title":"Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model","volume":"148","author":"Zelek","year":"2025","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.imbio.2025.153089_bb1540","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/awae278","article-title":"Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model","volume":"148","author":"Zelek","year":"2025","journal-title":"Brain"},{"issue":"7838","key":"10.1016\/j.imbio.2025.153089_bib1606","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2709-7","article-title":"Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency","volume":"588","author":"Zhang","year":"2020","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bb1550","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.imbio.2025.153089_bb1555","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/1570159X21666230203103910","article-title":"Emerging roles of microglia in blood-brain barrier integrity in aging and neurodegeneration","author":"Zhang","year":"2024","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.imbio.2025.153089_bb1560","first-page":"311","article-title":"Engineering antibody and protein therapeutics to cross the blood-brain barrier","volume":"5","author":"Zhao","year":"2022","journal-title":"Antib Ther."},{"issue":"10","key":"10.1016\/j.imbio.2025.153089_bb1565","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/biom14101204","article-title":"Astrocyte-mediated neuroinflammation in neurological conditions","volume":"14","author":"Zhao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.imbio.2025.153089_bb1570","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","article-title":"Updates on mouse models of Alzheimer's disase","volume":"19","author":"Zhong","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.imbio.2025.153089_bb1575","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1471-4159.2008.05558.x","article-title":"Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer\u2019s disease","volume":"106","author":"Zhou","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.imbio.2025.153089_bb1580","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.imbio.2025.153089_bb1585","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1007\/s12035-023-03393-w","article-title":"Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1\/NOX2 Pathway","volume":"60","author":"Zhou","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.imbio.2025.153089_bb1590","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf0141","article-title":"The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration","volume":"15","author":"Zhou","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imbio.2025.153089_bb1595","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100957","article-title":"The complement regulator Susd4 influences nervous-system function and neuronal morphology in mice","volume":"23","author":"Zhu","year":"2020","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.imbio.2025.153089_bb1600","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3390\/ijms22094675","article-title":"Aberrant complement system activation in neurological disorders","volume":"22","author":"Ziabska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.imbio.2025.153089_bib1608","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","article-title":"Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies","volume":"89","author":"Zuchero","year":"2016","journal-title":"Neuron."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:03:55Z","timestamp":1762261435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298525002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":326,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0171298525002232"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153089","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement therapeutics in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153089"}}